Showing 1 - 10 of 715
I analyze the effects of four types of medical innovation and cancer incidence on U.S. cancer mortality rates during …Under the assumption that there were no pre-dated factors that drove both innovation and mortality and that there would … have been parallel trends in mortality in the absence of innovation, the estimates indicate that there were three major …
Persistent link: https://www.econbiz.de/10012462770
We review the literature on financial intermediation in the process by which new medical therapeutics are financed, developed, and delivered. We discuss the contributing factors that lead to a key finding in the literature--underinvestment in biomedical R&D--and focus on the role that banks and...
Persistent link: https://www.econbiz.de/10013435156
The National Institutes of Health (NIH) plays a critical role in funding scientific endeavors in biomedicine that would be difficult to finance via private sources. One important mandate of the NIH is to fund innovative science that tries out new ideas, but many have questioned the NIH's ability...
Persistent link: https://www.econbiz.de/10012452861
The Ruth L. Kirschstein National Research Service Award (NRSA) program is a major research training program administered by the National Institutes of Health (NIH) with funds appropriated each year by Congress. This study examines the impact of NRSA postdoctoral fellowships on subsequent...
Persistent link: https://www.econbiz.de/10012453208
Recent policy attention has focused on proposals to reduce prices for drugs that have received public funding. From an implementation perspective, such policies rely on public disclosure of government support for research. In this paper, we highlight two conceptual problems with past attempts to...
Persistent link: https://www.econbiz.de/10012482567
Clinical trials following the "gold standard" of random assignment frequently use independent lotteries to allocate patients to treatment and control arms. However, independent assignment can generate treatment and control arms that are unbalanced (i.e. treatment and control populations with...
Persistent link: https://www.econbiz.de/10013477237
This paper considers the U.S. Small Business Innovation research (SBIR) program as a policy fostering academic … entrepreneurship. We highlight two main characteristics of the program that make it attractive as an entrepreneurship policy: early … the incidence of biomedical entrepreneurship through SBIR and describe some of the characteristics of these individuals …
Persistent link: https://www.econbiz.de/10012467229
Do intellectual property (IP) rights on existing technologies hinder subsequent innovation? Using newly-collected data …'s short-term IP had persistent negative effects on subsequent innovation relative to a counterfactual of Celera genes having …
Persistent link: https://www.econbiz.de/10012462442
The Plant Patent Act of 1930 was the first step towards creating property rights for biological innovation: it … varieties to examine whether the Act encouraged innovation. Nearly half of all plant patents between 1931 and 1970 were for … innovation: less than 20 percent of new roses were patented, European breeders continued to create most new roses, and there was …
Persistent link: https://www.econbiz.de/10012461674
Countries with larger increases in the share of cardiovascular drug doses that contained post-1990 or post-1995 ingredients had smaller increases in the cardiovascular disease hospital discharge rate, controlling for the quantity of cardiovascular medications consumed per person, the use of...
Persistent link: https://www.econbiz.de/10012464639